Mark A Findeis

This inventor holds 17 USPTO granted patents and 2 published patent applications, primarily in Amyloid Research. Top assignees: Praecis Pharmaceuticals, Inc., New England Deaconess Hospital Corporation. Active years: 1998-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark A Findeis. Retrieved from https://idiyas.com/inventor/mark-a-findeis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 70.6

Average Co-Inventor Count = 6.7

ph-index = 10

Forward Citations = 557(Granted Patents)

Location History:

Boston, MA (US) (1998 - 1999)
Cambridge, MA (US) (1998 - 2010)

Company Filing History:

14 out of 43

Praecis Pharmaceuticals, Inc.

patents

3 out of 53

New England Deaconess Hospital Corporation

patents

Years Active: 1998-2010

Loading Chart...

Areas of Expertise:

Amyloid Aggregation

D-Amino Acids

Peptide Compounds

FGF Receptor

Arterial Imaging

Synthetic Peptides

Beta-Amyloid

Modulators

Vascular Imaging

Peptide Modulation

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7803774 - Modulators of β-amyloid peptide aggregation (2010-09-28),

2. 7658917 - Modulators of amyloid aggregation (2010-02-09),

3. 7175828 - Modulators of β-amyloid peptide aggregation comprising D-amino acids (2007-02-13),

4. 6831066 - Modulators of &bgr;-amyloid peptide aggregation (2004-12-14),

5. 6689752 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2004-02-10),

6. 6610658 - Modulators of &mgr;-amyloid peptide aggregation (2003-08-26),

7. 6319498 - Modulators of amyloid aggregation (2001-11-20),

8. 6303567 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2001-10-16),

9. 6277826 - Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids (2001-08-21),

10. 6214795 - Peptide compounds useful for modulating FGF receptor activity (2001-04-10),

11. 5985242 - Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids (1999-11-16),

12. 5972890 - Synthetic peptides for arterial imaging (1999-10-26),

13. 5955055 - Synthetic peptides for arterial imaging at vascular imaging sites (1999-09-21),

14. 5854215 - Modulators of .beta.-amyloid peptide aggregation (1998-12-29),

15. 5854204 - A.beta. peptides that modulate .beta.-amyloid aggregation (1998-12-29),

Title: The Innovative Journey of Mark A. Findeis

Introduction: Mark A. Findeis, a talented inventor based in Cambridge, MA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: Mark A. Findeis holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Mark A. Findeis has had a successful career marked by his ability to turn innovative ideas into tangible solutions. His work has not only revolutionized industries but has also improved the lives of many.

Collaborations: Throughout his career, Mark A. Findeis has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market. His collaborative spirit and dedication to excellence have been instrumental in his success.

Conclusion: Mark A. Findeis stands as a shining example of an inventor whose relentless pursuit of innovation has led to groundbreaking discoveries and advancements in various fields. His passion for pushing the boundaries of what is possible continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents pending: